MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.
Published December 17, 2014 · Recall initiated: September 27, 2012
Summary
FDA records drug Class II recall D-0295-2015, published December 17, 2014 and initiated September 27, 2012. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 101,200 Vials; Lot: Lot 6003827, Exp. Date 04/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
What to do
Voluntary: Firm initiated · Letter
Get an email if MIDAZOLAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIDAZOLAM
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- U.S. Nationwide Including Puerto Rico
- UPC
- 0363323411183
- Lot
- Lot 6003827, Exp. Date 04/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APPFebruary 8, 2017
- FDAFentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only, 25December 17, 2014
- FDAONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APPDecember 17, 2014
- FDAFamotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mLDecember 17, 2014
- FDACYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APPDecember 17, 2014
- FDATikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDCDecember 17, 2014
Questions about this recall
Was MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25. recalled?
Yes. FDA published recall D-0295-2015 on December 17, 2014. Reported hazard: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIDAZOLAM. UPC: 0363323411183.